Study record

The Association Between Serum MOTS-c Levels and Myocardial Ischemia-Reperfusion Injury in Patients with Acute Myocardial Infarction: A Cross-Sectional Study

Peng L, Li Y, Duan X et al. · Biomedicines · 2026

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured lower postoperative peripheral serum MOTS-c in patients with myocardial ischemia-reperfusion injury than in those without, while preoperative peripheral and intracoronary levels did not differ. Reported that postoperative peripheral MOTS-c was an independent factor in multivariable regression, with an area under the curve of 0.648 for discriminating injury.

Limitations

Small single-centre cross-sectional sample; modest discrimination; no longitudinal or repeated sampling, and residual confounding by procedural factors is likely.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPatients with acute myocardial infarction undergoing percutaneous coronary intervention; peripheral and intracoronary serum MOTS-c
Populationadults with acute myocardial infarction undergoing percutaneous coronary intervention, with and without ischemia-reperfusion injury
DesignCross-sectional study
Sample size as reported72 patients (34 with myocardial ischemia-reperfusion injury, 38 without)
Control grouppatients without myocardial ischemia-reperfusion injury
Route (data field only)Not reported
Endpoints measuredperipheral serum MOTS-c; intracoronary MOTS-c; occurrence of myocardial ischemia-reperfusion injury; TIMI grade and Killip class; ROC discrimination
Pathways measuredOther
Research areasCardiovascular · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Small
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.